Filing Details
- Accession Number:
- 0001209191-21-069431
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-14 16:25:08
- Reporting Period:
- 2021-12-13
- Accepted Time:
- 2021-12-14 16:25:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
57725 | Lannett Co Inc | LCI | Pharmaceutical Preparations (2834) | 230787699 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1727305 | C Timothy Crew | 9000 State Road Philadelphia PA 19136 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-13 | 20,000 | $1.99 | 584,270 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Crew on November 10, 2021.
- The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.95 to $2.02. Thereporting person undertakes to provide to Lannett Company, Inc., any security holder of Lannett Company, Inc., or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price.